EBS FY 2010 Earnings — Emergent BioSolutions Inc. Revenue & Financial Results | Market Cap Arena

EBSEmergent BioSolutions Inc.

$422M

FY 2010 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$286M+21.9% YoY

Gross Profit

$239M83.5% margin

Operating Income

$74M25.7% margin

Net Income

$52M18.1% margin

EPS (Diluted)

$1.59

Cash Flow

Operating Cash Flow

$100M

Free Cash Flow

$77M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$500M

Total Liabilities

$127M

Stockholders' Equity

$369M

Cash & Equivalents

$169M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$286M	$235M	+21.9%
Gross Profit	$239M	$189M	+26.8%
Operating Income	$74M	$40M	+83.2%
Net Income	$52M	$31M	+66.0%